What Makes Urology Financially Challenging?
Urology billing is highly complex, involving procedures like cystoscopies, lithotripsy, and prostate biopsies that demand precise coding and documentation, errors can trigger denials and revenue leakage. Many practices also struggle with collecting upfront patient payments, leading to cash flow challenges.
Reimbursement trends have intensified pressure: over the past two decades, inflation-adjusted Medicare payments for urologic oncology procedures have declined by approximately 35–41%. Separate analysis shows a roughly 47% drop in reimbursement rates. Additionally, proposed 2025 Medicare policy changes could reduce RVU production for urology by around 1%, due to updates in resource valuations. These trends demand robust financial oversight to maintain practice viability.